Literature DB >> 29470920

Long-Term Microevolution of Pseudomonas aeruginosa Differs between Mildly and Severely Affected Cystic Fibrosis Lungs.

Jens Klockgether1, Nina Cramer1, Sebastian Fischer1, Lutz Wiehlmann1,2, Burkhard Tümmler1,3.   

Abstract

Chronic airway infections with Pseudomonas aeruginosa determine morbidity in most individuals with cystic fibrosis (CF). P. aeruginosa may persist for decades in CF lungs, which provides a rare opportunity to study the long-term within-host evolution of a bacterial airway pathogen. In this work, we sought to resolve the genetic adaptation of P. aeruginosa in CF lungs from the onset of colonization until the patient's death or permanent replacement by another P. aeruginosa clone. We followed the microevolution of the first persisting P. aeruginosa clone by whole-genome sequencing of serial isolates from highly divergent clinical courses of airway infection, i.e., a fatal outcome because of respiratory insufficiency within less than 15 years, or a rather normal daily life 25-35 years after acquisition of P. aeruginosa. Nonneutral mutations predominantly emerged in P. aeruginosa genes relevant for protection against and communication with signals from the lung environment, i.e., antibiotic resistance, cell wall components, and two-component systems. Drastic and loss-of-function mutations preferentially happened during the severe courses of infection, and the bacterial lineages of the mild courses more proficiently incorporated extra metabolic genes into their accessory genome. P. aeruginosa followed different evolutionary paths depending on whether the bacterium had taken up residence in a patient with CF and normal or already compromised lung function.

Entities:  

Keywords:  Pseudomonas aeruginosa; cystic fibrosis; microevolution

Mesh:

Year:  2018        PMID: 29470920     DOI: 10.1165/rcmb.2017-0356OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

Review 1.  Update in Cystic Fibrosis 2018.

Authors:  Bonnie W Ramsey; Gregory P Downey; Christopher H Goss
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

Review 2.  Transcriptional Profiling of Pseudomonas aeruginosa Infections.

Authors:  Janne G Thöming; Susanne Häussler
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  What Makes Pseudomonas aeruginosa a Pathogen?

Authors:  Burkhard Tümmler
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Laura Camus; Paul Briaud; François Vandenesch; Anne Doléans-Jordheim; Karen Moreau
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 5.  Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis.

Authors:  Elio Rossi; Ruggero La Rosa; Jennifer A Bartell; Rasmus L Marvig; Janus A J Haagensen; Lea M Sommer; Søren Molin; Helle Krogh Johansen
Journal:  Nat Rev Microbiol       Date:  2020-11-19       Impact factor: 60.633

6.  Polyclonality, Shared Strains, and Convergent Evolution in Chronic Cystic Fibrosis Staphylococcus aureus Airway Infection.

Authors:  Dustin R Long; Daniel J Wolter; Michael Lee; Mimi Precit; Kathryn McLean; Elizabeth Holmes; Kelsi Penewit; Adam Waalkes; Lucas R Hoffman; Stephen J Salipante
Journal:  Am J Respir Crit Care Med       Date:  2021-05-01       Impact factor: 21.405

7.  New Sequence Type ST3449 in Multidrug-Resistant Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient.

Authors:  Catalina Díaz-Ríos; Marta Hernández; David Abad; Laura Álvarez-Montes; Athanasia Varsaki; David Iturbe; Jorge Calvo; Alain A Ocampo-Sosa
Journal:  Antibiotics (Basel)       Date:  2021-04-23

8.  Compensatory evolution of Pseudomonas aeruginosa's slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis.

Authors:  Ruggero La Rosa; Elio Rossi; Adam M Feist; Helle Krogh Johansen; Søren Molin
Journal:  Nat Commun       Date:  2021-05-27       Impact factor: 14.919

Review 9.  Adapting to the Airways: Metabolic Requirements of Pseudomonas aeruginosa during the Infection of Cystic Fibrosis Patients.

Authors:  Ruggero La Rosa; Helle Krogh Johansen; Søren Molin
Journal:  Metabolites       Date:  2019-10-16

10.  Why? - Successful Pseudomonas aeruginosa clones with a focus on clone C.

Authors:  Changhan Lee; Jens Klockgether; Sebastian Fischer; Janja Trcek; Burkhard Tümmler; Ute Römling
Journal:  FEMS Microbiol Rev       Date:  2020-11-24       Impact factor: 16.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.